Home > Insider Trading > Filing (0001104659-18-010448)

Filing Details

Accession Number:: 0001104659-18-010448
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-02-16 20:14:27
Reporting Period:: 2018-02-13

Accepted Time:: 2018-02-16 20:14:27
Original Submission Date:: 2018-02-15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
805928	Axogen Inc.	AXGN	Electromedical & Electrotherapeutic Apparatus (3845)	411301878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1530935	Mark Jamie Grooms	13631 Progress Boulevard, Suite 400 Alachua FL 32615		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-02-13	7,100	$26.20	202,595	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2018-02-13	3,200	$26.22	9,073	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2018-02-14	32,936	$26.72	169,659	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2018-02-14	9,073	$26.71	0	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2018-02-15	43,403	$27.11	126,256	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee.
These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.